TLSI

NASDAQ open

TriSalus Life Sciences

2.32 USD
▲+0.14+6.44%
盘后 3.54 0.00%
2026-11-20
市值
$143.14M
市盈率
—
EPS
-0.49
股息率
—
52 周区间
2.17 – 7.95
成交量
362.53K
Beta
0.51
目标价
7.80
52W 低 2.1752W 高 7.95
价格走势

公司简介

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device...